Main therapies and point of action in Niemann type C disease.

Por um escritor misterioso

Descrição

Main therapies and point of action in Niemann type C disease.
Protocol for initiation of miglustat treatment in NP-C. Reproduced
Main therapies and point of action in Niemann type C disease.
Understanding the phenotypic variability in Niemann-Pick disease
Main therapies and point of action in Niemann type C disease.
Miglustat in Niemann-Pick disease type C patients: a review
Main therapies and point of action in Niemann type C disease.
Molecular mechanism(s) of neurodegeneration in Niemann-Pick type C
Main therapies and point of action in Niemann type C disease.
Frontiers Pre-clinical Mouse Models of Neurodegenerative
Main therapies and point of action in Niemann type C disease.
Marta, with Niemann Pick C, fights for a cure with gene therapy
Main therapies and point of action in Niemann type C disease.
IJMS, Free Full-Text
Main therapies and point of action in Niemann type C disease.
Niemann-Pick disease type C. The diagram represents subtypes and
Main therapies and point of action in Niemann type C disease.
Thiadiazole Carbamates: Potent Inhibitors of Lysosomal Acid Lipase
Main therapies and point of action in Niemann type C disease.
Potential treatment for Niemann-Pick type C, a rare
Main therapies and point of action in Niemann type C disease.
A novel strategy for delivering Niemann‐Pick type C2 proteins
de por adulto (o preço varia de acordo com o tamanho do grupo)